This stock is no longer traded. It was delisted on June 16, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
WebsiteBuilding No. 2
Beijing, 102629
China
Summary of Apr 27's posts. Generated by AI.
Summary of Aug 25's posts. Generated by AI.
Summary of Aug 27's posts. Generated by AI.
Investors talking about YS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.